Cargando…
NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
Treatment of cancer in humans requires a thorough understanding of the multiple pathways by which it develops. Recent studies suggest that nuclear receptor coactivator 4 (NCOA4) may be a predictive biomarker for renal cancer. In the present work, TCGA, GEPIA, and several bioinformatics approaches we...
Autores principales: | Gu, Chenzheng, Chang, Wenjing, Wu, Junlu, Yao, Yiwen, Liu, Gege, Yuan, Yi, Quan, Wenqiang, Sun, Zujun, Shang, Anquan, Li, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225891/ https://www.ncbi.nlm.nih.gov/pubmed/35756082 http://dx.doi.org/10.1155/2022/5242437 |
Ejemplares similares
-
PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022) -
Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1
por: Shang, Anquan, et al.
Publicado: (2020) -
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis
por: Shang, Anquan, et al.
Publicado: (2020) -
Retinoic Acid-Induced Gene G(RIG-G) as a Novel Monitoring Biomarker in Leukemia and Its Clinical Applications
por: Wang, Fei, et al.
Publicado: (2021) -
Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling
por: Ji, Ping, et al.
Publicado: (2019)